ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.660
-0.010 (-0.60%)
Feb 13, 2026, 4:00 PM EST - Market closed
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $41.24 million as of February 13, 2026. Its market cap has increased by 515.48% in one year.
Market Cap
41.24M
Enterprise Value
43.45M
1-Year Change
515.48%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $41.24M, a decrease of -48.13%. That is a compound annual growth rate of -13.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 40.60M | -21.62% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 43.67M |
| OS Therapies | 42.96M |
| Xilio Therapeutics | 42.62M |
| Aligos Therapeutics | 42.52M |
| Apollomics | 42.47M |
| CEL-SCI | 41.20M |
| Lite Strategy | 41.18M |
| LeonaBio | 40.52M |